[F&N] YoY Annualized Quarter Result on 30-Sep-2005 [#4]

Stock
[F&N] FRASER & NEAVE HOLDINGS BHD
Announcement Date
08-Nov-2005
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2005
Quarter
30-Sep-2005 [#4]
Profit Trend
QoQ- 2.77%
YoY- 13.34%
Quarter Report
Latest QR
Upcoming QR
F&N's Result
F&N's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Revenue 3,674,216 2,865,068 1,943,630 1,935,106 1,728,054 1,611,119 1,521,988 15.80%
PBT 239,672 220,905 194,186 183,751 157,066 122,794 122,315 11.85%
Tax -59,941 -55,328 -40,604 -44,461 -40,644 -38,844 -34,597 9.58%
NP 179,731 165,577 153,582 139,290 116,422 83,950 87,718 12.68%
-
NP to SH 166,845 152,871 142,827 131,950 116,422 83,950 87,718 11.29%
-
Tax Rate 25.01% 25.05% 20.91% 24.20% 25.88% 31.63% 28.29% -
Total Cost 3,494,485 2,699,491 1,790,048 1,795,816 1,611,632 1,527,169 1,434,270 15.98%
-
Net Worth 1,183,601 1,158,113 1,114,834 1,084,129 1,050,290 1,000,255 973,455 3.30%
Dividend
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Div 142,887 121,869 116,434 107,842 28,482 35,723 32,091 28.23%
Div Payout % 85.64% 79.72% 81.52% 81.73% 24.46% 42.55% 36.59% -
Equity
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Net Worth 1,183,601 1,158,113 1,114,834 1,084,129 1,050,290 1,000,255 973,455 3.30%
NOSH 356,506 356,342 356,177 356,621 356,030 357,234 356,577 -0.00%
Ratio Analysis
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
NP Margin 4.89% 5.78% 7.90% 7.20% 6.74% 5.21% 5.76% -
ROE 14.10% 13.20% 12.81% 12.17% 11.08% 8.39% 9.01% -
Per Share
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
RPS 1,030.62 804.02 545.69 542.62 485.37 451.00 426.83 15.81%
EPS 46.80 42.90 40.10 37.00 32.70 23.50 24.60 11.30%
DPS 40.08 34.20 32.69 30.24 8.00 10.00 9.00 28.23%
NAPS 3.32 3.25 3.13 3.04 2.95 2.80 2.73 3.31%
Adjusted Per Share Value based on latest NOSH - 356,530
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
RPS 1,001.75 781.14 529.92 527.60 471.14 439.26 414.96 15.80%
EPS 45.49 41.68 38.94 35.98 31.74 22.89 23.92 11.29%
DPS 38.96 33.23 31.75 29.40 7.77 9.74 8.75 28.23%
NAPS 3.227 3.1575 3.0395 2.9558 2.8636 2.7271 2.6541 3.30%
Price Multiplier on Financial Quarter End Date
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Date 30/09/08 28/09/07 29/09/06 30/09/05 30/09/04 30/09/03 30/09/02 -
Price 9.05 8.05 6.20 5.55 4.16 3.48 3.50 -
P/RPS 0.88 1.00 1.14 1.02 0.86 0.77 0.82 1.18%
P/EPS 19.34 18.76 15.46 15.00 12.72 14.81 14.23 5.24%
EY 5.17 5.33 6.47 6.67 7.86 6.75 7.03 -4.98%
DY 4.43 4.25 5.27 5.45 1.92 2.87 2.57 9.49%
P/NAPS 2.73 2.48 1.98 1.83 1.41 1.24 1.28 13.44%
Price Multiplier on Announcement Date
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Date 06/11/08 06/11/07 07/11/06 08/11/05 08/11/04 10/11/03 08/11/02 -
Price 8.35 7.75 6.50 5.65 4.48 3.66 3.50 -
P/RPS 0.81 0.96 1.19 1.04 0.92 0.81 0.82 -0.20%
P/EPS 17.84 18.07 16.21 15.27 13.70 15.57 14.23 3.83%
EY 5.60 5.54 6.17 6.55 7.30 6.42 7.03 -3.71%
DY 4.80 4.41 5.03 5.35 1.79 2.73 2.57 10.96%
P/NAPS 2.52 2.38 2.08 1.86 1.52 1.31 1.28 11.94%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment